119 related articles for article (PubMed ID: 20189425)
1. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia.
Valensi P; Cosson E
Diabetes Metab; 2010 Apr; 36(2):91-6. PubMed ID: 20189425
[TBL] [Abstract][Full Text] [Related]
2. Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia.
Sejil S; Janand-Delenne B; Avierinos JF; Habib G; Labastie N; Raccah D; Vague P; Lassmann-Vague V
Diabet Med; 2006 Nov; 23(11):1186-91. PubMed ID: 17054593
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective?
Beller GA
J Am Coll Cardiol; 2007 May; 49(19):1918-23. PubMed ID: 17498575
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker.
Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B
J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of screening for silent myocardial ischaemia according to the ALFEDIAM-SFC 2004 Guidelines in a population of diabetic patients.
Hiebel A; Fagot-Campagna A; Fosse S; Varroud-Vial M; Weill A; Penfornis A
Diabetes Metab; 2010 Sep; 36(4):286-92. PubMed ID: 20434384
[TBL] [Abstract][Full Text] [Related]
6. Silent myocardial ischaemia and risk factors in a diabetic Afro-Caribbean population.
Blanchet Deverly A; Amara M; Larifla L; Velayoudom-Céphise FL; Roques F; Kangambega P; Hue K; Foucan L
Diabetes Metab; 2011 Dec; 37(6):533-9. PubMed ID: 21764347
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of silent coronary artery disease in type 2 diabetes.
Zellweger MJ
Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561
[TBL] [Abstract][Full Text] [Related]
8. [Silent ischemic cardiopathy: which diabetics to examine?].
Charpentier G; Riveline JP; Lardoux H; Mathieu E; Requeda E; Varroud-Vial M
Arch Mal Coeur Vaiss; 2000 Dec; 93 Spec No 4():25-32. PubMed ID: 11296459
[TBL] [Abstract][Full Text] [Related]
9. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes.
Barthelemy O; Jacqueminet S; Rouzet F; Isnard R; Bouzamondo A; Le Guludec D; Grimaldi A; Metzger JP; Le Feuvre C
Arch Cardiovasc Dis; 2008 Sep; 101(9):539-46. PubMed ID: 19041838
[TBL] [Abstract][Full Text] [Related]
10. Reviewing myocardial silent ischemia: specific patient subgroups.
Xanthos T; Ekmektzoglou KA; Papadimitriou L
Int J Cardiol; 2008 Feb; 124(2):139-48. PubMed ID: 17566575
[TBL] [Abstract][Full Text] [Related]
11. [Frequency of silent ischemic heart disease in patients with diabetes mellitus].
Negrusz-Kawecka M; Moszczyńska-Stulin J; Zytkiewicz-Jaruga D; Salomon P
Pol Merkur Lekarski; 1997 Aug; 3(14):53-6. PubMed ID: 9480174
[TBL] [Abstract][Full Text] [Related]
12. Myocardial ischemia: a silent epidemic in Type 2 diabetes patients.
Le Feuvre C; Jacqueminet S; Barthelemy O
Future Cardiol; 2011 Mar; 7(2):183-90. PubMed ID: 21453025
[TBL] [Abstract][Full Text] [Related]
13. The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients.
Cosson E; Nguyen MT; Chanu B; Balta S; Takbou K; Valensi P
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):557-65. PubMed ID: 22502874
[TBL] [Abstract][Full Text] [Related]
14. [Silent myocardial ischemia in diabetic patients: to screen or not to screen?].
Meyer P
Rev Med Suisse; 2005 Jun; 1(22):1505-7, 1509-10. PubMed ID: 16025890
[TBL] [Abstract][Full Text] [Related]
15. Screening asymptomatic diabetic patients for coronary artery disease: why not?
Miller TD; Redberg RF; Wackers FJ
J Am Coll Cardiol; 2006 Aug; 48(4):761-4. PubMed ID: 16904546
[TBL] [Abstract][Full Text] [Related]
16. [Silent myocardial ischemia].
Swidnicka-Szuszkowska B
Pol Merkur Lekarski; 1999 Oct; 7(40):153-8. PubMed ID: 10835903
[TBL] [Abstract][Full Text] [Related]
17. The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes.
Rutter MK; Nesto RW
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):26-35. PubMed ID: 17179927
[TBL] [Abstract][Full Text] [Related]
18. Silent myocardial ischaemia in patients with type II diabetes mellitus and its relation with autonomic dysfunction.
Sukhija R; Dhanwal D; Gambhir DS; Dewan R
Indian Heart J; 2000; 52(5):540-6. PubMed ID: 11256776
[TBL] [Abstract][Full Text] [Related]
19. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.
Scognamiglio R; Negut C; Ramondo A; Tiengo A; Avogaro A
J Am Coll Cardiol; 2006 Jan; 47(1):65-71. PubMed ID: 16386666
[TBL] [Abstract][Full Text] [Related]
20. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study.
Faglia E; Manuela M; Antonella Q; Michela G; Vincenzo C; Maurizio C; Roberto M; Alberto M
Am Heart J; 2005 Feb; 149(2):e1-6. PubMed ID: 15846252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
